Evidence map›Paper›PMID 34110415›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2021

Interbatch Reliability of Blood-Based Cytokine and Chemokine Measurements in Community-Dwelling Older Adults: A Cross-Sectional Study.

Cutter A Lindbergh, Breton M Asken, Kaitlin B Casaletto, Fanny M Elahi, Lauren A Goldberger, Corrina Fonseca, Michelle You, Alexandra C Apple, Adam M Staffaroni, Ryan Fitch and 5 more

Open access · greenAbstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Cutter A LindberghMemory and Aging Center, Department of Neurology, University of California San Francisco, USA.
Breton M AskenMemory and Aging Center, Department of Neurology, University of California San Francisco, USA.
Kaitlin B CasalettoMemory and Aging Center, Department of Neurology, University of California San Francisco, USA.
Fanny M ElahiMemory and Aging Center, Department of Neurology, University of California San Francisco, USA.
Lauren A GoldbergerMemory and Aging Center, Department of Neurology, University of California San Francisco, USA.
Corrina FonsecaMemory and Aging Center, Department of Neurology, University of California San Francisco, USA.
Michelle YouMemory and Aging Center, Department of Neurology, University of California San Francisco, USA.
Alexandra C AppleMemory and Aging Center, Department of Neurology, University of California San Francisco, USA.
Adam M StaffaroniMemory and Aging Center, Department of Neurology, University of California San Francisco, USA.
Ryan FitchMemory and Aging Center, Department of Neurology, University of California San Francisco, USA.
Will Rivera ContrerasMemory and Aging Center, Department of Neurology, University of California San Francisco, USA.
Paul WangMemory and Aging Center, Department of Neurology, University of California San Francisco, USA.
Anna KarydasMemory and Aging Center, Department of Neurology, University of California San Francisco, USA.
Joel H KramerMemory and Aging Center, Department of Neurology, University of California San Francisco, USA.
Hillblom Aging Network
University Memory and Aging Center · USUniversity of California, San Francisco · US

Funding

Research Education ComponentP30AG062422 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Serggio Carlo Lanata · 2019 to 2026
$36.9M
UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI JIN, LEE-WAY · 1991 to 2020
$28.3M
PrPSc SPECIFIC INTERACTION WITH NOVEL PrP-Fc FUSION PROTEINSP50AG023501 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MILLER, BRUCE L · 2004 to 2018
$27.1M
Mechanisms of Executive Decline in Normal AgingR01AG032289 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Kaitlin B Casaletto, JOEL H KRAMER · 2009 to 2026
$8.3M
Biological Predictors Of Brain Aging Trajectories Diversity Supplement: African American Outreach And The Intersection Between Social Determinants Of Health And Biomarkers Of Degenerative DiseaseRF1AG032289 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRAMER, JOEL H · 2020 to 2021
$5.3M
Novel imaging and endothelial biomarkers of small vessel cerebrovascular diseaseUH3NS100608 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DECARLI, CHARLES, KRAMER, JOEL H · 2018 to 2020
$3.5M
Effects of chronic inflammation on brain structure and functionR01AG048234 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRAMER, JOEL H · 2015 to 2019
$3.2M
Novel Imaging and Biofluid Biomarkers of Small Vessel Cerebrovascular DiseaseUF1NS100608 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRAMER, JOEL H · 2021 to 2021
$2.5M
Can Behavior Shape Neural Health? Identifying Modifiable Factors to Prevent Cognitive Decline in AgeK23AG058752 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CASALETTO, KAITLIN B · 2018 to 2022
$994k
Optimizing Clinical Trial Endpoints in Frontotemporal DementiaK23AG061253 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STAFFARONI, ADAM MARK · 2019 to 2023
$946k
CSRD VA IK2 CX002180NIA NIH HHS K23 AG058752NIA NIH HHS K23 AG061253NIA NIH HHS L30 AG057123NIA NIH HHS P30 AG010129NIA NIH HHS P50 AG023501NIA NIH HHS R01 AG032289NIA NIH HHS R01 AG048234NIA NIH HHS RF1 AG032289NIA NIH HHS UCSF ADRC P30AG062422NINDS NIH HHS UF1 NS100608NINDS NIH HHS UH3 NS100608
6 · The paper itself

Abstract

Blood-based inflammatory markers hold considerable promise for diagnosis and prognostication of age-related neurodegenerative disease, though a paucity of research has empirically tested how reliably they can be measured across different experimental runs ("batches"). We quantified the interbatch reliability of 13 cytokines and chemokines in a cross-sectional study of 92 community-dwelling older adults (mean age = 74; 48% female). Plasma aliquots from the same blood draw were parallelly processed in 2 separate batches using the same analytic platform and procedures (high-performance electrochemiluminescence by Meso Scale Discovery). Interbatch correlations (Pearson's r) ranged from small and nonsignificant (r = .13 for macrophage inflammatory protein-1 alpha [MIP-1α]) to very large (r > .90 for interferon gamma [IFNγ], interleukin-10 [IL-10], interferon gamma-induced protein 10 [IP-10], MIP-1β, thymus and activation-regulated chemokine [TARC]) with most markers falling somewhere in between (.67 ≤ r ≤ .90 for IL-6, tumor necrosis factor alpha [TNF-α], Eotaxin, Eotaxin-3, monocyte chemoattractant protein-1 [MCP-1], MCP-4, macrophage-derived chemokine [MDC]). All markers, except for IL-6 and MCP-4, showed significant differences in absolute values between batches, with discrepancies ranging in effect size (Cohen's d) from small to moderate (0.2 ≤ |d| ≤ 0.5 for IL-10, IP-10, MDC) to large or very large (0.68 ≤ |d| ≤ 1.5 for IFNγ, TNF-α, Eotaxin, Eotaxin-3, MCP-1, MIP-1α, MIP-1β, TARC). Relatively consistent associations with external variables of interest (age, sex, systolic blood pressure, body mass index, cognition) were observed across batches. Taken together, our results suggest heterogeneity in measurement reliability of blood-based cytokines and chemokines, with some analytes outperforming others. Future work is needed to evaluate the generalizability of these findings while identifying potential sources of batch effect measurement error.

Indexed as

CytokinesNeurodegenerative DiseasesAgedChemokine CCL26Chemokine CCL3Chemokine CCL4Chemokine CXCL10Cross-Sectional StudiesFemaleHumansIndependent LivingInterferon-gammaInterleukin-10Interleukin-6MaleReproducibility of ResultsChemokine CCL26Chemokine CCL3Chemokine CCL4Chemokine CXCL10CytokinesInterferon-gammaInterleukin-10Interleukin-6Tumor Necrosis Factor-alphaBiomarkerImmune activationMeso Scale DiscoveryPlasmaProteomics

Identifiers

PMID34110415
PMCPMC8514070
OpenAlexW3172984521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.